Mobility is an excellent indicator of overall heath, so much so that it has been referred to as the '6th' or 'functional' vital sign. The post explains why and how the data could be used to provide early indications of neurological decline and future quality of life issues.

The Mobilise-D technologies and methodologies have brought about a step-change in our ability to measure and understand mobility performance. This post provides an overview of those methods and technologies, as well as the associated technical validation study.

How are mobility endpoints used in pivotal trials for conditions impacting mobility? Not as commonly as they should be, and certainly not with the specificity they should be.